These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies. Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting. Ahirrao M; Shrotriya S Drug Dev Ind Pharm; 2017 Oct; 43(10):1686-1693. PubMed ID: 28574732 [TBL] [Abstract][Full Text] [Related]
4. Nanostructured cubosomes in an Patil RP; Pawara DD; Gudewar CS; Tekade AR J Liposome Res; 2019 Sep; 29(3):264-273. PubMed ID: 30501444 [TBL] [Abstract][Full Text] [Related]
5. Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies. Faisal MM; Gomaa E; Ibrahim AE; El Deeb S; Al-Harrasi A; Ibrahim TM AAPS PharmSciTech; 2024 May; 25(5):95. PubMed ID: 38710921 [TBL] [Abstract][Full Text] [Related]
6. Nanosized Cubosomal Thermogelling Dispersion Loaded with Saquinavir Mesylate to Improve Its Bioavailability: Preparation, Optimization, in vitro and in vivo Evaluation. Hosny KM Int J Nanomedicine; 2020; 15():5113-5129. PubMed ID: 32764940 [TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of innovative triamcinolone acetonide encapsulated cubosomal Patil R; Patil AS; Chougule K; Gaude Y; Masareddy RS Drug Dev Ind Pharm; 2024 Jan; 50(1):68-77. PubMed ID: 38148515 [TBL] [Abstract][Full Text] [Related]
9. Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution. Abdelrahman FE; Elsayed I; Gad MK; Badr A; Mohamed MI Int J Pharm; 2015 Jul; 490(1-2):281-91. PubMed ID: 26026251 [TBL] [Abstract][Full Text] [Related]
10. Intranasal Delivery of Granisetron to the Brain via Nanostructured Cubosomes-Based In Situ Gel for Improved Management of Chemotherapy-Induced Emesis. Eissa EM; Elkomy MH; Eid HM; Ali AA; Abourehab MAS; Alsubaiyel AM; Naguib IA; Alsalahat I; Hassan AH Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890270 [TBL] [Abstract][Full Text] [Related]
11. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery. Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226 [TBL] [Abstract][Full Text] [Related]
12. Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study. Salem HF; Kharshoum RM; Abou-Taleb HA; Naguib DM AAPS PharmSciTech; 2019 May; 20(5):181. PubMed ID: 31049748 [TBL] [Abstract][Full Text] [Related]
13. Formulation and Evaluation of Resveratrol Loaded Cubosomal Nanoformulation for Topical Delivery. Kurangi B; Jalalpure S; Jagwani S Curr Drug Deliv; 2021; 18(5):607-619. PubMed ID: 32881670 [TBL] [Abstract][Full Text] [Related]
14. Intranasal versus intraperitoneal Myrj 59-stabilized cubosomes: A potential armamentarium of effective anti-diabetic therapy. Mansour M; Elmowafy E; Gad HA Colloids Surf B Biointerfaces; 2021 Mar; 199():111534. PubMed ID: 33373841 [TBL] [Abstract][Full Text] [Related]
15. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats. Abdelmonem R; El Nabarawi M; Attia A Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of a novel lidocaine-loaded cubosomal gel for prolonged local anesthesia. Jiang J; Wu H; Zou Z J Biomater Appl; 2022 Aug; 37(2):315-323. PubMed ID: 35373629 [TBL] [Abstract][Full Text] [Related]
17. Sustained delivery of salbutamol from cubosomal gel for management of paediatric asthma: Zhang H; Cui Y; Zhang X; Yuan X; Xu D; Zhang L J Microencapsul; 2022 May; 39(3):252-260. PubMed ID: 35384781 [TBL] [Abstract][Full Text] [Related]
18. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. Khan S; Patil K; Bobade N; Yeole P; Gaikwad R J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503 [TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Zaki NM; Awad GA; Mortada ND; Abd Elhady SS Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822 [TBL] [Abstract][Full Text] [Related]
20. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting. Shah B; Khunt D; Misra M; Padh H Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]